Edit Content

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Oseltamivir Market to reach USD XX billion by the end of 2030

Global Oseltamivir Market Size study & Forecast, by Product (Capsule, Suspension, Other Product Types), by Application (Influenza A Influenza B, Other Applications), and Regional Analysis, 2023-2030

Product Code: HLSDT-21473379
Publish Date: 20-10-2023
Page: 200

Global Oseltamivir Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Oseltamivir, commonly known by its brand name Tamiflu, is an antiviral medication used to treat and prevent influenza (flu) infections caused by the influenza A and B viruses. It belongs to a class of drugs known as neuraminidase inhibitors. Oseltamivir works by inhibiting the activity of the neuraminidase enzyme, which is essential for the influenza virus to spread and infect other cells in the body. Oseltamivir helps to reduce the severity and duration of flu symptoms and also decreases the risk of complications associated with the flu, such as pneumonia. The Oseltamivir market is expanding because of factors such as the rising prevalence of influenza virus infections and the increase in the number of research and development activities.

Infection with the influenza virus is becoming more common. Since influenza is known to be a substantial source of illness and mortality in people, treatments have been developed and put into place to lessen the financial and medical load. For instance, according to the Centers for Disease Control and Prevention data, the influenza virus infection caused 8–13 million symptomatic illnesses, 3.7–6.1 million medical visits, 82,000–170,000 hospitalizations, and 5,000–14,000 fatalities from early October 2021 to mid-June 2022. Over 2.8 million respiratory specimens underwent testing in clinical labs for the influenza virus. 98.6% of specimens for influenza A and 1.4% for influenza B both tested positive overall, making up 4.5% of the total. A positive result for influenza was found in 0.1% to 9.9% of the samples per week. Additionally, according to WHO statistics released in February 2021, approximately 490,516 specimens were analyzed in 2021–2022 by WHO GISRS laboratories. Of these, 12,368 tested positive for the flu, with 8,423 having influenza A and 3,945 having influenza B. As a result, the high prevalence of influenza infection in the population is anticipated to enhance the demand for the medicine oseltamivir for its treatment, driving the market’s expansion. In addition, government initiatives to increase access to oseltamivir and rising healthcare expenditures are creating lucrative opportunities for market growth. However, the side effects associated with oseltamivir treatment and availability of alternative treatments stifle market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Oseltamivir Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the dominance of key market players, the rising prevalence of diseases, the presence of well-established healthcare infrastructure, and rising spending on research and development activities. Whereas, Asia Pacific is projected to have significant growth owing to factors such as rising disease prevalence, rising government funding for drug development, and rising healthcare expenditure in the region.

Major market player included in this report are:
F. Hoffmann-La Roche Ltd
Cipla Inc.
Zydus Cadila
NATCO Pharma Limited
Macleods Pharmaceuticals Ltd
Amneal Pharmaceuticals LLC
Alembic Pharmaceuticals Limited
Hetero Healthcare Limited
Lupin Limited
Strides Pharma Science Limited

Recent Developments in the Market:
Ø In December 2022, The Administration for Strategic Preparedness and Response (ASPR) of the U.S. Department of Health and Human Services (HHS) has announced that it will make an additional supply of Tamiflu available to jurisdictions through the SNS.
Ø In January 2022, Strides Pharma Science Ltd received approval from the American health organisation to market its generic version of oseltamivir phosphate for oral suspension, a medication used to treat influenza-related illnesses. These would lead to rise the company market share.

Global Oseltamivir Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Product, Application, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:
Other Product Types
By Application:
Influenza A
Influenza B
Other Applications

By Region:

North America


Asia Pacific
South Korea

Latin America

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Oseltamivir Market, by Region, 2020-2030 (USD Billion)
1.2.2. Oseltamivir Market, by Product, 2020-2030 (USD Billion)
1.2.3. Oseltamivir Market, by Application, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Oseltamivir Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Oseltamivir Market Dynamics
3.1. Oseltamivir Market Impact Analysis (2020-2030)
3.1.1. Market Drivers Rising prevalence of influenza virus infections Increase in the number of research and development activities
3.1.2. Market Challenges The side effects associated with oseltamivir treatment Availability of alternative treatments
3.1.3. Market Opportunities Government initiatives to increase access to oseltamivir Rising healthcare expenditures
Chapter 4. Global Oseltamivir Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Oseltamivir Market, by Product
5.1. Market Snapshot
5.2. Global Oseltamivir Market by Product, Performance – Potential Analysis
5.3. Global Oseltamivir Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
5.4. Oseltamivir Market, Sub Segment Analysis
5.4.1. Capsule
5.4.2. Suspension
5.4.3. Other Product Types
Chapter 6. Global Oseltamivir Market, by Application
6.1. Market Snapshot
6.2. Global Oseltamivir Market by Application, Performance – Potential Analysis
6.3. Global Oseltamivir Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
6.4. Oseltamivir Market, Sub Segment Analysis
6.4.1. Influenza A
6.4.2. Influenza B
6.4.3. Other Applications
Chapter 7. Global Oseltamivir Market, Regional Analysis
7.1. Top Leading Countries
7.2. Top Emerging Countries
7.3. Oseltamivir Market, Regional Market Snapshot
7.4. North America Oseltamivir Market
7.4.1. U.S. Oseltamivir Market Product breakdown estimates & forecasts, 2020-2030 Application breakdown estimates & forecasts, 2020-2030
7.4.2. Canada Oseltamivir Market
7.5. Europe Oseltamivir Market Snapshot
7.5.1. U.K. Oseltamivir Market
7.5.2. Germany Oseltamivir Market
7.5.3. France Oseltamivir Market
7.5.4. Spain Oseltamivir Market
7.5.5. Italy Oseltamivir Market
7.5.6. Rest of Europe Oseltamivir Market
7.6. Asia-Pacific Oseltamivir Market Snapshot
7.6.1. China Oseltamivir Market
7.6.2. India Oseltamivir Market
7.6.3. Japan Oseltamivir Market
7.6.4. Australia Oseltamivir Market
7.6.5. South Korea Oseltamivir Market
7.6.6. Rest of Asia Pacific Oseltamivir Market
7.7. Latin America Oseltamivir Market Snapshot
7.7.1. Brazil Oseltamivir Market
7.7.2. Mexico Oseltamivir Market
7.8. Middle East & Africa Oseltamivir Market
7.8.1. Saudi Arabia Oseltamivir Market
7.8.2. South Africa Oseltamivir Market
7.8.3. Rest of Middle East & Africa Oseltamivir Market

Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Company 1
8.1.2. Company 2
8.1.3. Company 3
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. F. Hoffmann-La Roche Ltd Key Information Overview Financial (Subject to Data Availability) Product Summary Recent Developments
8.3.2. Cipla Inc.
8.3.3. Zydus Cadila
8.3.4. NATCO Pharma Limited
8.3.5. Macleods Pharmaceuticals Ltd
8.3.6. Amneal Pharmaceuticals LLC
8.3.7. Alembic Pharmaceuticals Limited
8.3.8. Hetero Healthcare Limited
8.3.9. Lupin Limited
8.3.10. Strides Pharma Science Limited
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com


Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now